NURS 663 TEST 2 PRACTICE EXAM UPDATED QUESTIONS AND COMPLETE SOLUTIONS VERIFIED 100% ALREADY GRADED A+ 2024-2025 Mini-Mental State Examination (MMSE) Widely used tests for cognitive function in older adults, covering arithmetic, memory, and orientation. Montreal Cognitive Assessment (MoCA) Comprehensive screening tool evaluating attention, memory, language, and executive functions. Clock Drawing Test Quick test for cognitive impairment, especially executive function and visuospatial abilities. Neuropsychological Testing Battery of tests measuring various cognitive functions to provide a detailed profile of strengths and weaknesses. Alzheimer's Disease Gradual memory loss, confusion, language difficulty, mood changes; pathology includes amyloid plaques and neurofibrillary tangles. Delirium Acute onset, fluctuating consciousness, inattention, and disorganized thinking; often secondary to medical conditions. Frontotemporal DegenerationPersonality/behavior changes, language difficulties, executive dysfunction; atrophy in frontal and temporal lobes. Lewy Body Disease Cognitive impairment, visual hallucinations, parkinsonism, fluctuations in alertness; pathology involves Lewy bodies. Prion Disease (Creutzfeldt-Jakob Disease) Rapidly progressive dementia, myoclonus, ataxia; caused by misfolded prion proteins. Vascular Disease Stepwise decline in cognitive function, stroke history, focal neurological signs; pathology includes infarcts and white matter changes. Risks of Prescribing Antipsychotics for People with Dementia Increased mortality, cardiovascular events, stroke, infections; can worsen cognitive decline. Goal of Treatment for Older Adults with Neurocognitive Disorders